Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Magnesium Sulphate in Acute Exacerbation of COPD
NCT05699720Completed
- Sponsor
- King Edward Medical University
- Start
- Jan 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of magnesium sulfate in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by King Edward Medical University. Primary endpoint: In-Hospital Outcome at 5 days. Started Jan 2019; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT05699720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05699720.